Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Spinal Disorders & Techniques|December 14, 2011
Comparative analysis of isocentric 3-dimensional C-arm fluoroscopy and biplanar fluoroscopy for anterior screw fixation in odontoid fracturesNikolay L Martirosyan, Samuel Kalb, Daniel D Cavalcanti, et al.
Urologic Oncology|January 13, 2011
The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinomaK T Ow, H Mameghan, A Lochhead, et al.
World Neurosurgery|February 9, 2011
A history of the Barrow Neurological InstituteRichard A Lochhead, Adib A Abla, Alim P Mitha, et al.
Ebiomedicine|July 3, 2015
DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down SyndromeSònia Najas, Juan Arranz, Pamela A Lochhead, et al.
The American Journal of Managed Care|September 8, 2000
Disease management program improves asthma outcomesJ R Jowers, A L Schwartz, D G Tinkelman, et al.
Cell Cycle (Georgetown, Tex.)|March 10, 2016
Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferationPamela A Lochhead, Jonathan Clark, Lan-Zhen Wang, et al.
Nature Communications|March 15, 2020
Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitorsPamela A Lochhead, Julie A Tucker, Natalie J Tatum, et al.
European Journal of Medicinal Chemistry|December 12, 2025
New mechanistic insights into targeted protein degradation using Raman-active theranostic hydrophobic tagsCraig F Steven, Manasa Punaha Ravindra, Martin Lee, et al.
Neurosurgery|April 3, 2008
Identification of A2B5+CD133- tumor-initiating cells in adult human gliomasAlfred T Ogden, Allen E Waziri, Richard A Lochhead, et al.
Cellular and Molecular Life Sciences : CMLS|September 9, 2015
Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndromeAnne L Ashford, Tom P J Dunkley, Mark Cockerill, et al.
Pageof 5